Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

The importance of supplementary immunisation activities to prevent measles outbreaks during the COVID-19 pandemic in Kenya.
MBURU, CN; OJAL, J; Chebet, R; Akech, D; Karia, B; Tuju, J; Sigilai, A; ABBAS, K; JIT, M; FUNK, S; Smits, G; Van Gageldonk, PG M; Van der Klis, FR M; Tabu, C; Nokes, DJ; LSHTM CMMID COVID-19 Working Group,; SCOTT, J; FLASCHE, S; ADETIFA, I;
2021
BMC medicine, (2021).19 1 10.1186/s12916-021-01906-9.
Genomic reconstruction of the SARS-CoV-2 epidemic in England.
Vöhringer, HS; Sanderson, T; Sinnott, M; De Maio, N; Nguyen, T; Goater, R; Schwach, F; Harrison, I; Hellewell, J; Ariani, CV; Gonçalves, S; Jackson, DK; Johnston, I; Jung, AW; Saint, C; Sillitoe, J; Suciu, M; Goldman, N; Panovska-Griffiths, J; Wellcome Sanger Institute COVID-19 Surveillance Te,; COVID-19 Genomics UK (COG-UK) Consortium*,; Birney, E; Volz, E; FUNK, S; Kwiatkowski, D; ... Gerstung, M.
2021
NATURE, (2021).600 7889 10.1038/s41586-021-04069-y.
How modelling can help steer the course set by the World Health Organization 2021-2030 roadmap on neglected tropical diseases.
Clark, J; Stolk, WA; Basáñez, M-G; Coffeng, LE; Cucunubá, ZM; Dixon, MA; Dyson, L; Hampson, K; MARKS, M; MEDLEY, GF; Pollington, TM; Prada, JM; Rock, KS; Salje, H; Toor, J; Hollingsworth, TD;
2021
Gates Open Research, (2021).5, 10.12688/gatesopenres.13327.1.
Effect of evidence updates on key determinants of measles vaccination impact: a DynaMICE modelling study in ten high-burden countries.
FU, H; Abbas, K; Klepac, P; VAN ZANDVOORT, K; Tanvir, H; Portnoy, A; JIT, M;
2021
medRxiv (2021). 10.1101/2021.05.28.21257964.
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial.
AFOLABI, MO; ISHOLA, D; MANNO, D; Keshinro, B; Bockstal, V; Rogers, B; Owusu-Kyei, K; Serry-Bangura, A; Swaray, I; Lowe, B; Kowuor, D; Baiden, F; Mooney, T; Smout, E; Köhn, B; Otieno, GT; Jusu, M; Foster, J; Samai, M; Deen, GF; LARSON, H; LEES, S; Goldstein, N; Gallagher, KE; Gaddah, A; ... EBL3001 study group,
2021
Lancet Infectious Diseases, (2021).22 1 10.1016/S1473-3099(21)00128-6.
Correction: Practical considerations for measuring the effective reproductive number, Rt.
Gostic, KM; McGough, L; Baskerville, EB; ABBOTT, S; Joshi, K; Tedijanto, C; Kahn, R; Niehus, R; Hay, JA; De Salazar, PM; Hellewell, J; MEAKIN, S; MUNDAY, JD; BOSSE, NI; Sherrat, K; Thompson, RN; White, LF; Huisman, JS; Scire, J; Bonhoeffer, S; Stadler, T; Wallinga, J; FUNK, S; Lipsitch, M; Cobey, S;
2021
PLoS Computational Biology, (2021).17 12 10.1371/journal.pcbi.1009679.
UK prevalence of underlying conditions which increase the risk of severe COVID-19 disease: a point prevalence study using electronic health records.
Walker, JL; GRINT, DJ; STRONGMAN, H; EGGO, RM; Peppa, M; MINASSIAN, C; MANSFIELD, KE; RENTSCH, CT; DOUGLAS, IJ; MATHUR, R; WONG, AY S; Quint, JK; Andrews, N; Bernal, JL; SCOTT, JA; Ramsay, M; SMEETH, L; MCDONALD, HI;
2021
BMC public health, (2021).21 1 10.1186/s12889-021-10427-2.
Effectiveness of BNT162b2 and ChAdOx1 against SARS-CoV-2 household transmission: a prospective cohort study in England.
CLIFFORD, S; Waight, P; Hackman, J; Hué, S; Gower, CM; Kirsebom, FC M; Skarnes, C; Letley, L; Bernal, JL; Andrews, N; FLASCHE, S; MILLER, E;
2021
(2021). 10.1101/2021.11.24.21266401.
Severity of Severe Acute Respiratory System Coronavirus 2 (SARS-CoV-2) Alpha Variant (B.1.1.7) in England.
GRINT, DJ; WING, K; Houlihan, C; Gibbs, HP; EVANS, SJ W; WILLIAMSON, E; MCDONALD, HI; BHASKARAN, K; Evans, D; Walker, AJ; Hickman, G; NIGHTINGALE, E; SCHULTZE, A; RENTSCH, CT; Bates, C; Cockburn, J; Curtis, HJ; Morton, CE; Bacon, S; Davy, S; WONG, AY S; Mehrkar, A; TOMLINSON, L; DOUGLAS, IJ; Mathur, R; ... EGGO, RM.
2021
Clinical infectious diseases, (2021).75 1 10.1093/cid/ciab754.
Evaluating the impact of a continued maternal pertussis immunisation programme in England: A modelling study and cost-effectiveness analysis.
SANDMANN, F; JIT, M; Andrews, N; Buckley, HL; Campbell, H; Ribeiro, S; Sile, B; Stowe, J; Tessier, E; Ramsay, M; Amirthalingam, G; Choi, YH;
2021
Vaccine, (2021).39 32 10.1016/j.vaccine.2021.06.042.